Analysts expect Camp4 Therapeutics Corp to report revenue of 2.39 M for Q3 26, against a range of 2.20 M to 2.58 M. The most recent reported quarter, Q2 26, came in at 1.78 M, a 16.3% beat against the 1.53 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 652,000.00 | 858,000.00 | 1.50 M | 795,000.00 | 300,000.00 | 1.29 M | 1.78 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 251,453.33 | 729,177.48 | 220,639.08 | 591,866.68 | 469,606.94 | 495,609.61 | 1.16 M | 1.65 M | 2.58 M | 2.50 M | 2.42 M | 2.47 M | 2.58 M | 2.90 M | 794,939.43 | 665,900.31 | ||||||||||
| Low Estimate | 214,584.17 | 674,509.48 | 197,826.82 | 501,290.92 | 434,527.44 | 426,416.19 | 993,048.43 | 1.41 M | 2.20 M | 2.25 M | 2.24 M | 2.21 M | 2.26 M | 2.43 M | 745,878.25 | 597,949.43 | ||||||||||
| Consensus Estimate | 233,018.75 | 701,843.48 | 209,232.95 | 546,578.80 | 452,067.19 | 461,012.90 | 1.08 M | 1.53 M | 2.39 M | 2.37 M | 2.33 M | 2.34 M | 2.42 M | 2.67 M | 770,408.84 | 631,924.87 |
Analysts expect Camp4 Therapeutics Corp to report earnings per share of -0.17 for Q3 26, against a range of -0.18 to -0.16. The most recent reported quarter, Q2 26, came in at -0.58, a 176.2% miss against the -0.21 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -24.19 | -0.77 | -0.62 | -0.62 | -0.55 | -0.86 | -0.32 | -0.58 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -1.07 | -0.83 | -0.62 | -0.65 | -0.49 | -0.46 | -0.19 | -0.19 | -0.16 | -0.14 | -0.14 | -0.14 | 2.42 | 4.43 | -1.90 | -3.06 | ||||||||||
| Low Estimate | -1.21 | -0.95 | -0.68 | -0.73 | -0.53 | -0.50 | -0.21 | -0.23 | -0.18 | -0.16 | -0.18 | -0.16 | 2.26 | 3.97 | -2.24 | -3.50 | ||||||||||
| Consensus Estimate | -1.14 | -0.89 | -0.65 | -0.69 | -0.51 | -0.48 | -0.20 | -0.21 | -0.17 | -0.15 | -0.16 | -0.15 | 2.34 | 4.20 | -2.07 | -3.28 |
Pull Wall Street consensus for Camp4 Therapeutics Corp (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CAMP&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CAMP", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CAMP&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();